Epilepsy Breakthroughs;

Send us Fan Mail Epilepsy care is changing so fast that what used to feel like “one drug and one surgical option” is turning into an entire toolbox of smarter, more personalized choices. We walk through the biggest advances from 2023 to September 2026 and explain what they could mean for people living with epilepsy, caregivers, and anyone curious about where modern neurology is headed. We dig into the evolving medication landscape, including newly approved therapies, promising Phase 3 results, and why the FDA sometimes puts a partial clinical hold on a drug candidate. From there we zoom out to the broader shift away from broad symptom management and toward precision medicine, where treatment decisions increasingly hinge on better evidence, better timing, and better targeting of the underlying cause. We also get into the tech that’s reshaping diagnosis and follow-up: brain-responsive neurostimulation results, ultra-long-term EEG monitoring that can outperform seizure diaries, and AI-driven tools that detect subtle lesions radiologists may miss, especially in pediatric epilepsy. Finally, we explore the genetic frontier, including gene pathway discoveries, gene therapy progress, and even personalized “N-of-1” treatments designed for a single patient’s mutation. If any of this connects to your life, we want to hear from you. Subscribe, share this with someone who cares about epilepsy research, and leave a review, then tell us: have newer epilepsy treatments helped you, or made things harder? We apologize for the word salad bar, but we had never actually heard some of these words pronounced before. Support the show